These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16764958)

  • 1. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
    Korantzopoulos P; Kolettis TM; Galaris D; Goudevenos JA
    Int J Cardiol; 2007 Feb; 115(2):135-43. PubMed ID: 16764958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress: a possible pathogenesis of atrial fibrillation.
    Huang CX; Liu Y; Xia WF; Tang YH; Huang H
    Med Hypotheses; 2009 Apr; 72(4):466-7. PubMed ID: 19103473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
    Kim YM; Guzik TJ; Zhang YH; Zhang MH; Kattach H; Ratnatunga C; Pillai R; Channon KM; Casadei B
    Circ Res; 2005 Sep; 97(7):629-36. PubMed ID: 16123335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
    Korantzopoulos P; Kolettis T; Siogas K; Goudevenos J
    Med Sci Monit; 2003 Sep; 9(9):RA225-9. PubMed ID: 12960937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of thiazolidinediones in atrial fibrillation.
    Liu T; Korantzopoulos P; Li G; Li J
    Int J Cardiol; 2008 Aug; 128(1):129-30. PubMed ID: 17655946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation.
    Liu T; Li G
    Int J Cardiol; 2010 Nov; 145(1):140-2. PubMed ID: 19616323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target.
    Van Wagoner DR
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):306-13. PubMed ID: 18791466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of oxidative stress on atrial fibrillation in humans.
    Kim YH; Lim DS; Lee JH; Shim WJ; Ro YM; Park GH; Becker KG; Cho-Chung YS; Kim MK
    Exp Mol Med; 2003 Oct; 35(5):336-49. PubMed ID: 14646586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.
    Kim YM; Kattach H; Ratnatunga C; Pillai R; Channon KM; Casadei B
    J Am Coll Cardiol; 2008 Jan; 51(1):68-74. PubMed ID: 18174039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological remodeling in atrial fibrillation].
    Goette A; Lendeckel U
    Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonchannel drug targets in atrial fibrillation.
    Goette A; Lendeckel U
    Pharmacol Ther; 2004 Apr; 102(1):17-36. PubMed ID: 15056496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in the genesis and perpetuation of atrial fibrillation.
    Engelmann MD; Svendsen JH
    Eur Heart J; 2005 Oct; 26(20):2083-92. PubMed ID: 15975993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the association of inflammation and atrial fibrillation.
    Patel P; Dokainish H; Tsai P; Lakkis N
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1064-70. PubMed ID: 20455973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the pathogenesis of atrial fibrillation.
    Kourliouros A; Savelieva I; Kiotsekoglou A; Jahangiri M; Camm J
    Am Heart J; 2009 Feb; 157(2):243-52. PubMed ID: 19185630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
    Savelieva I; Camm J
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.
    Shiroshita-Takeshita A; Schram G; Lavoie J; Nattel S
    Circulation; 2004 Oct; 110(16):2313-9. PubMed ID: 15477401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy.
    Korantzopoulos P; Kokkoris S; Kountouris E; Protopsaltis I; Siogas K; Melidonis A
    Int J Cardiol; 2008 Apr; 125(3):e51-3. PubMed ID: 17400309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation: a possible pathogenic link to atrial fibrillation.
    Pan M; Zhu JH; Jiang WP; Liu ZH; Li HM; Yu XH; Yang XJ
    Med Hypotheses; 2006; 67(6):1305-7. PubMed ID: 16824699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.